We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$712B
AUM Growth
+$31.8B
Cap. Flow
+$2.48B
Cap. Flow %
0.35%
Top 10 Hldgs %
21.18%
Holding
2,600
New
72
Increased
1,394
Reduced
949
Closed
59

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.27B
2
LLY icon
Eli Lilly
LLY
+$1.64B
3
NVDA icon
NVIDIA
NVDA
+$1.59B
4
RHT
Red Hat Inc
RHT
+$1.55B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Technology 18.88%
2 Healthcare 16.96%
3 Financials 13.79%
4 Consumer Discretionary 13.57%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRGO icon
176
Perrigo
PRGO
$1.78B
$901M 0.13%
18,911,635
+819,399
+5% +$39M
BDXA
177
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
$894M 0.13%
14,375,698
-666,889
-4% -$39.5M
MSCI icon
178
MSCI
MSCI
$40.8B
$886M 0.12%
3,709,591
+935,665
+34% +$210M
TMX
179
DELISTED
Terminix Global Holdings, Inc.
TMX
$884M 0.12%
16,975,326
-68,747
-0.4% -$3.54M
TME icon
180
Tencent Music
TME
$14.3B
$881M 0.12%
58,749,764
+57,596,675
+4,995% +$910M
ICUI icon
181
ICU Medical
ICUI
$4.55B
$876M 0.12%
3,478,883
+640,425
+23% +$148M
IDXX icon
182
Idexx Laboratories
IDXX
$46.2B
$876M 0.12%
3,180,724
+787,736
+33% +$194M
HD icon
183
Home Depot
HD
$353B
$875M 0.12%
4,207,419
+4,281
+0.1% +$854K
L icon
184
Loews
L
$23.1B
$867M 0.12%
15,861,648
-3,311,412
-17% -$170M
IP icon
185
International Paper
IP
$22.1B
$859M 0.12%
20,930,416
+1,120,798
+6% +$47.5M
BWXT icon
186
BWX Technologies
BWXT
$15.5B
$856M 0.12%
16,433,098
-442,472
-3% -$22.1M
ST icon
187
Sensata Technologies
ST
$6.73B
$853M 0.12%
17,416,662
+40,985
+0.2% +$1.95M
RPM icon
188
RPM International
RPM
$14.9B
$850M 0.12%
13,910,720
-237,473
-2% -$14M
MGA icon
189
Magna International
MGA
$18.8B
$850M 0.12%
17,095,464
+1,471,578
+9% +$72.7M
EXAS
190
DELISTED
Exact Sciences
EXAS
$848M 0.12%
7,184,601
-1,108,575
-13% -$112M
QSR icon
191
Restaurant Brands International
QSR
$25.6B
$845M 0.12%
12,150,685
-1,778,730
-13% -$119M
XLNX
192
DELISTED
Xilinx Inc
XLNX
$844M 0.12%
7,157,646
-731,604
-9% -$85.3M
AEP icon
193
American Electric Power
AEP
$67.3B
$830M 0.12%
9,429,008
-203,873
-2% -$17.6M
ASND icon
194
Ascendis Pharma A/S
ASND
$16.7B
$827M 0.12%
7,178,036
+2,509,034
+54% +$300M
WAB icon
195
Wabtec
WAB
$50.3B
$825M 0.12%
11,496,753
+1,961,064
+21% +$139M
GILD icon
196
Gilead Sciences
GILD
$168B
$818M 0.11%
12,109,533
+90,251
+0.8% +$5.94M
IR icon
197
Ingersoll Rand
IR
$33B
$818M 0.11%
23,643,913
+4,946,203
+26% +$160M
DXCM icon
198
DexCom
DXCM
$33.8B
$818M 0.11%
21,827,336
+17,075,704
+359% +$537M
ZEN
199
DELISTED
ZENDESK INC
ZEN
$813M 0.11%
9,133,023
+3,920,837
+75% +$337M
DOCU
200
DocuSign
DOCU
$11.3B
$812M 0.11%
16,338,342
+6,051,597
+59% +$323M

Similar funds

T. Rowe Price Associates's Q2 2019 Portfolio in Review

As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
  • T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
  • T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
  • T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
  • T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
  • T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.